Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Must have relapsing MS
Must have lifetime tetanus vaccination
Agree to receive 2010/2011 seasonal influenza vaccine and tetanus toxoid booster injection
You may not be if
Patients with a type of MS that is not relapsing
Patients with history of chronic immune disease
Certain cancers
Diabetic patients with certain eye disorders
Patients who are on certain immunosuppressive medications or heart medications
Patients with certain heart conditions
Patients with certain lung conditions
Patients who have already received the 2010/2011 seasonal influenza vaccine
Clareo Health | Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
